Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
Photo Synthesis would be as plants grow from the sun or gain energy from the sun, where as Cellular Respiration is when cells divide into two or more. (I believe)
Answer:
<u>Origin:</u> In biology, origin can be described as the location where the muscle joins a stationary bone and as a result, no movement occurs.
<u>Insertion: </u>In anatomy, insertion can be described as the point of attachment which allows movement of a bone to occur. It moves when the muscles contract.
<u>Tendon:</u> In biology, the tendon can be described as a type of connective tissue which attaches a bone to a muscle.
